COVID Resources


Review

Olfactory dysfunction in the COVID-19 outbreak
Izquierdo-Dominguez A, Rojas-Lechuga MJ, Mullol J, Alobid I
J Investig Allergol Clin Immunol 2020; Vol. 30(5)
doi: 10.18176/jiaci.0567
[summary] [PDF full-Text]

Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19
Rodrigo-Muñoz JM, Sastre B, Cañas JA, Gil-Martínez M, Redondo N, del Pozo V
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0624
[summary] [PDF full-Text]

Upper and Lower Airways Functional Examination in Asthma and Respiratory Allergic Deseases. Considerations in the SARS-CoV-2 Post-Pandemic Situation
Olaguibel JM, Alobid I, Alvarez Puebla M, Crespo-Lessmann A, Domínguez Ortega J, García-Rio F, Izquierdo-Domínguez A, Mullol J, Plaza V, Quirce S, Rojas-Lechuga MJ, Valvere-Monge M, Sastre J
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0625
[summary] [PDF full-Text]

Treating COVID-19: Review of drug hypersensitivity reactions
Dordal Culla MT, Herrera-Lasso Regás V, Martí-Garrido J, Rodríguez Cumplido D, Vázquez-Revuelta P, Lleonart Bellfill R
J Investig Allergol Clin Immunol 2020; Vol. 30(6)
doi: 10.18176/jiaci.0588
[summary] [PDF full-Text]

Original Articles

Smell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings - a multicenter cross-sectional study
Izquierdo-Domínguez A, Rojas-Lechuga MJ, Chiesa-Estomba C, Calvo-Henríquez C, Ninchritz-Becerra E, Soriano-Reixach M, Poletti-Serafini D, Villarreal IM, Maza-Solano JM, Moreno-Luna R, Villarroel PP, Mateos-Serrano B, Agudelo D, Valcarcel F, del Cuvillo A, Santamaría A, Mariño-Sánchez F, Aguilar J, Vergés P, Inciarte A, Soriano A, Mullol J, Alobid I
J Investig Allergol Clin Immunol 2020; Vol. 30(5)
doi: 10.18176/jiaci.0595
[summary] [PDF full-Text] [Supplemental Materials]

High frequency of smell and taste dysfunctions in allergy health care professionals suffering from COVID-19
Antolín-Amérigo D, Cubero JL, Colás C, Alobid I, Mullol J, Valero A
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0670
[summary] [PDF full-Text]

Practitioner’s Corner

Allergen Immunotherapy in the era of SARS-CoV-2
Compalati E, Erlewyn-Lajeunesse M, Ali FR, Ojeda Fernández P, Garcia Nuñez I, Frati F, Mistrello G
J Investig Allergol Clin Immunol 2020; Vol. 30(6)
doi: 10.18176/jiaci.0568
[summary] [PDF full-Text]

Serum concentrations of interleukin-6 (IL-6) in the general adult population: possible implications for anti-IL-6 therapy in SARS-Cov-2 infection and IL-6-related diseases
Alende-Castro V, Alonso-Sampedro M, Gude F, Gonzalez-Quintela A
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0601
[summary] [PDF full-Text]

Pertinence of Telehealth in a Rush Conversion to Virtual Allergy Practice during the COVID-19 Outbreak
González-Pérez R, Sánchez-Machín I, Poza-Guedes P, Matheu V, Álava-Cruz C, Mederos Luís E
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0597
[summary] [PDF full-Text]

Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain
Barroso B, Valverde-Monge M, Cañas JA, Rodrigo-Muñoz JM, Gonzalez-Cano B, Villalobos-Violan V, Betancor D, Gomez-Cardeñosa A, Vallejo-Chamorro G, Baptista L, Villalobos-Vilda C, Ortega-Martin L, Gómez-López A, Sanchez-Pernaute O, Romero-Bueno F, Rodriguez-Nieto MJ, Del Pozo V, Sastre J, COVID FJD-TEAM
J Investig Allergol Clin Immunol 2020; Vol. 30(5)
doi: 10.18176/jiaci.0627
[summary] [PDF full-Text] [Supplemental Materials]

Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2: a case description
Pecori D, Della Siega P, Sozio E, Barbano E, Mazzoran L, Zanichelli A, Sbrana F, Federico I, Bassi F, Fabris M, Vendramin I, Sbrojavacca R, Tascini C
J Investig Allergol Clin Immunol 2021; Vol. 31(5)
doi: 10.18176/jiaci.0659
[summary] [PDF full-Text] [Supplemental Materials]

Olfactory and Gustatory dysfunction in Pediatric Population with Coronavirus Disease (COVID-19)
Bernaola Abraira M, Bartha De Las Peñas I, López-Araujo GA, Escudero Diez C, Rodríguez del Río P, Morales-Cabeza C, Bazire Batiz R, Ibáñez Sandín MD
J Investig Allergol Clin Immunol 2021; Vol. 31(3)
doi: 10.18176/jiaci.0677
[summary] [PDF full-Text] [Supplemental Materials]

Safety of new MRNA Vaccines Against COVID-19 in Severe Allergic Patients
Rojas-Pérez-Ezquerra P, Crespo Quirós J, Tornero Molina P, Baeza Ochoa de Ocáriz ML, Zubeldia Ortuño JM
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0683
[summary] [PDF full-Text] [Supplemental Materials]

Letters to the Editor

The rediscovery of hydroxychloroquine in allergic diseases in the COVID-19 era
Bonzano L, Cassone G, Tarallo L, Pellacani G
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0575
[summary] [PDF full-Text]

COVID-19 & Allergy: Allergists Workload During the Pandemic
Fernández-de-Alba I, Brigido C, García-Gutierrez I, Antolín-Amérigo D, Sánchez-García S
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0632
[summary] [PDF full-Text] [Supplemental Materials]

The century of mRNA vaccines: COVID-19 vaccines and allergy
Ortega Rodríguez NR, Audícana Berasategui MT, de la Hoz Caballer B, Valero Santiago A
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0665
[summary] [PDF full-Text]

Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines
Caballero ML, Quirce S
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0667
[summary] [PDF full-Text]

Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T, Álvarez-Twose I
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0680
[summary] [PDF full-Text]